首页 | 本学科首页   官方微博 | 高级检索  
     


Exploratory efficacy endpoints in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)
Affiliation:1. Department of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, QC, Canada;2. MUHC Vaccine Study Centre – Research Institute, McGill University Health Centre, Montreal, QC, Canada;3. Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec, Quebec City, QC, Canada;4. Department of Microbiology, Infectious Diseases and Immunology, University of Montreal, Montreal, QC, Canada;1. Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada;2. Division of Vaccine Preventable Diseases, Public Health Agency of Canada, Ottawa, ON, Canada;3. Department of Pediatrics, Division of Infectious Diseases, The Montreal Children''s Hospital, McGill University, Montreal, QC, Canada;4. Quebec Institute of Public Health, Montreal, QC, Canada;5. McGill University Health Centre, Vaccine Study Centre, Research Institute of the MUHC, Montreal, QC, Canada;1. Department of internal medicine and cardiology, Blida University Hospital, 09000 Algeria;2. Department of epidemiology, Blida University Hospital, 09000 Algeria;3. Center of cardiology and angiology, 47000 Ghardaïa, Algeria;1. Department of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, South-1 West-16, Chuo-ku, Sapporo 060-8556, Japan;2. Department of Microbiology, Sapporo Medical University School of Medicine, South-1 West-16, Chuo-ku, Sapporo 060-8556, Japan;3. SANWA Clinic, Oodori2-1, Samani-cho, Hokkaido 058-0014, Japan;1. Vaccination and Travel Medicine Centre, Poliklinika, Hradec Králové, Czech Republic;2. Novartis Vaccines, Emeryville, CA, USA;3. Novartis Vaccines, Basel, Switzerland
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号